Atlas Trials

The Effect of Inhaled Nitric Oxide on Dyspnea and Exercise Tolerance in Interstitial Lung Disease.

Clinical trial NCT04181359 · WITHDRAWN

Trial details

NCT number
NCT04181359
Sponsor
University of Alberta
Status
WITHDRAWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Dyspnea
Start date
2024-09-01
Primary completion
2025-12-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.